Do not start, adjust, or discontinue any GLP-1 therapy without consulting your healthcare provider
When you are living with complex chronic conditions like Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), dysautonomia, or Mast Cell Activation Syndrome (MCAS), the search for answers can feel like navigating a labyrinth in the dark
Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in alzheimers disease
[DOI] [PubMed] [Google Scholar] 59.Lee D, Stinner D, Mir H: Quadriceps and patellar tendon ruptures
Thiol proteins, redox modulation and parenchymal lung disease
BPC-157/TB-500 (T-4) Research Peptide Combination BPC-157/TB-500 (T-4) TB-500 (T-4): This synthetic peptide comes from Thymosin Beta-4, a natural protein in the body